Authors


Thaddeus Grasela, PharmD, PhD

Latest:

Individual Treatment Effects: Implications for Research, Clinical Practice, and Policy

A framework for researchers, providers, payers, or public health bodies identifies when it is most critical to distinguish between "average" population and individual patient response.


Benjamin Eng, MD

Latest:

Systematic Analysis of Outcomes Evaluations Applied to Drug Management Programs

Adopting quality measurement standards for drug management programs might increase the effectiveness and long-term sustainability of positive health outcomes for patients.


Shivani Sampathkumar, BS

Latest:

Pricing of Monoclonal Antibody Therapies: Higher If Used for Cancer?

The annual price of monoclonal antibody therapies used in oncology and hematology is about $100,000 higher than those used in other disease states.



Deborah Taira Juarez, ScD

Latest:

Factors Affecting Medication Adherence Trajectories for Patients With Heart Failure

Nonwhite race, smoking, and increasing body mass index were associated with the lowest adherence trajectories for patients with heart failure, with adherence dropping off within the first year.


John Schulz, BA

Latest:

Medicare Shared Savings Program: Public Reporting and Shared Savings Distributions

Analysis of publicly reported organizational characteristics, shared savings distribution plans, and early financial success of accountable care organizations in the Medicare Shared Savings Program.


Bruce Barth

Latest:

Charitable Assistance Among Economically Vulnerable Cancer Patients: Patient Access Network Foundation Summary Statistics 2011-2015

This report shows that among people who are eligible for charitable assistance to cover out-of-pocket (OOP) prescription drug expenses, those with cancer have higher per-claim and per-person OOP costs than their counterparts with other health conditions.



Nate Brown, BA

Latest:

A Step in the Digital Direction: From Paper Logs to Electronic Data Capture

Research documentation is a critical aspect of running a clinical trial. Key patient information such as informed consent, adverse events (AEs), concomitant medications, and medical and surgical histories are collected and used to determine patient safety and efficacy as the trial proceeds. Ultimately, the sponsor may make decisions—ranging from modifying the dose of the investigational drug to closing the study due to AEs—based on the data collected.





Dawn Weddle, RD

Latest:

Food as Medicine: Impact on Diabetes Management

This article addresses what employers need to know about food as medicine and offers practical steps to reduce barriers for their employee populations.


Sarah Muench, PharmD

Latest:

Impact of a Pharmacist-Managed Diabetes Clinic on Quality Measures

This study evaluated a pharmacist-managed diabetes clinic to determine its impact on diabetes-related quality measures.(For Tables and Figures, please access the PDF on last page.)



Amer Budayr, MD

Latest:

Trends in Mortality Following Hip Fracture in Older Women

Within an integrated healthcare setting, temporal trends demonstrate reductions in mortality risk after hip fracture in older women, with mortality risk lower for Asians and Hispanics.






Derek Weycker, PhD

Latest:

Benefits and Risks of Live Attenuated Influenza Vaccine in Young Children

Use of live attenuated influenza vaccine in young children has a favorable benefit-risk profile.


Mary Vaughan-Sarrazin, PhD

Latest:

Elderly Veterans With Dual Eligibility for VA and Medicare Services: Where Do They Obtain a Colonoscopy?

This study examines factors impacting the receipt of an outpatient colonoscopy by VA or non-VA providers in older veterans dually eligible for VA/Medicare benefits.




Michael N. Neuss, MD

Latest:

Advancing Performance Measurement in Oncology

The American Society of Clinical Oncology Quality Oncology Practice Initiative has grown to include 973 practices as of 2010. Practices demonstrated rates of end-of-life care and other measures of quality.




Robert W. Dubois, MD

Latest:

The Value of Specialty Pharmaceuticals - A Systematic Review

This study examines whether patients treated with specialty pharmaceuticals have improved outcomes compared with patients treated with conventional therapies, and evaluates costs associated with these treatments.


Roman Buff, MD

Latest:

Frequency of and Harm Associated With Primary Care Safety Incidents

Physicians' and nurses' assessments of the frequency and harm of incidents can be a supplemental method to study patient safety in the primary care office.


AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo